FIELD: medicine.
SUBSTANCE: invention refers to medicine, nutriology, dietology, immunology, endocrinology. Method includes correction of metabolic disorders in persons of working age with increased body weight index (BWI). Against the backdrop of a low-calorie diet, preparations of metabolic action – Fucus Jelly Native Gastro, Hepamin and Stimbiphid – are taken. Fucus Jelly Native Gastro is taken in amount of 40 g 2 times day 20–30 minutes before meals, mixing the preparation with water or a fruit beverage. If BWI is increased by 1-2 units from upper limit of norm – within 1.5 months, increased BWI by 3-4 units from upper limit of norm – to its reduction by 2 units, increased BWI by more than 4 units from upper limit of norm – to its reduction by 3 units. Hepamin is taken with meals 3 times a day: 2 tablets with high BWI from 1 to 3 units from upper limit of norm to BWI reduction by 1 unit; 3 tablets with high BWI for more than 3 units from upper limit of norm to reduction of BWI by 2 units. Stimbiphide – on the first day of 1 tablet 2 times a day – in the morning and in the evening, in second – 2 tablets 2 times a day, in third – 2 tablets 3 times a day, then take 3 tablets 3 times a day until normalizing BWI.
EFFECT: method enables long-term preservation of positive biochemical effects, normal intestinal microbiota, bringing the required micro- and macronutrients into the body balance, bringing the blood glucose, lipidogram, hepatic enzymes, number of fat deposits, immunogram values by reducing the amount of adipose tissue and extracellular fluid, increasing active cell and musculoskeletal body weight, operability and intensity of metabolism.
1 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTION OF DISRUPTION OF ORGANISM DIGESTIVE SYSTEM HOMEOSTASIS | 2015 |
|
RU2599503C1 |
METABOLIC CORRECTION METHOD IN PATIENTS WITH PROTEIN-ENERGY INSUFFICIENCY (PEI) | 2019 |
|
RU2714315C1 |
TECHNOLOGY OF REHABILITATION-PREVENTIVE NUTRITIONAL SUPPORT IN CORONAVIRUS INFECTION | 2020 |
|
RU2735723C1 |
METHOD FOR CORRECTING METABOLIC DISORDERS IN PERIMENOPAUSAL WOMEN | 2021 |
|
RU2767879C1 |
METHOD OF TREATING AND IMPROVING LIFE QUALITY OF PATIENTS SUFFERING FROM DYSPEPSIA SYNDROME IN COMBINATION WITH OBESITY | 2012 |
|
RU2523558C2 |
METHOD OF CORRECTING VAGINAL DYSBIOSIS IN CASE OF METABOLIC SYNDROME | 2012 |
|
RU2484669C1 |
METHOD FOR CORRECTION OF DYSLIPIDEMIA IN WOMEN WITH METABOLIC SYNDROME DURING MENOPAUSAL TRANSITION | 2021 |
|
RU2771426C1 |
METHOD DETERMINING TACTICS OF CARRYING OUT OF MEDICAL ACTIONS AT PATIENTS WITH METABOLIC SYNDROME AGAINST ARTERIAL HYPERTENSIA | 2007 |
|
RU2337612C1 |
METHOD OF TREATING PATIENTS WITH DYSPEPSIA SYNDROME COMBINED WITH OVERWEIGHT | 2012 |
|
RU2528641C2 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE ACCOMPANYING METABOLIC SYNDROME | 2018 |
|
RU2686042C1 |
Authors
Dates
2020-01-17—Published
2019-08-26—Filed